The Potential of Targeting Autophagy-Related Non-coding RNAs in the Treatment of Alzheimer’s and Parkinson’s Diseases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The Potential of Targeting Autophagy-Related Non-coding RNAs in the Treatment of Alzheimer’s and Parkinson’s Diseases ; volume:44 ; number:1 ; day:10 ; month:3 ; year:2024 ; pages:1-16 ; date:12.2024
Cellular and molecular neurobiology ; 44, Heft 1 (10.3.2024), 1-16, 12.2024
- Urheber
-
Talebi Taheri, Abdolkarim
Golshadi, Zakieh
Zare, Hamidreza
Alinaghipour, Azam
Faghihi, Zahra
Dadgostar, Ehsan
Tamtaji, Zeinab
Aschner, Michael
Mirzaei, Hamed
Tamtaji, Omid Reza
Nabavizadeh, Fatemeh
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10571-024-01461-w
- URN
-
urn:nbn:de:101:1-2405122111393.627905697220
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Talebi Taheri, Abdolkarim
- Golshadi, Zakieh
- Zare, Hamidreza
- Alinaghipour, Azam
- Faghihi, Zahra
- Dadgostar, Ehsan
- Tamtaji, Zeinab
- Aschner, Michael
- Mirzaei, Hamed
- Tamtaji, Omid Reza
- Nabavizadeh, Fatemeh
- SpringerLink (Online service)
Ähnliche Objekte (12)
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease